ATE499069T1 - Flüssige polymerlosung zur kontrollierten freisetzung von bioaktiven substanzen - Google Patents

Flüssige polymerlosung zur kontrollierten freisetzung von bioaktiven substanzen

Info

Publication number
ATE499069T1
ATE499069T1 AT04076699T AT04076699T ATE499069T1 AT E499069 T1 ATE499069 T1 AT E499069T1 AT 04076699 T AT04076699 T AT 04076699T AT 04076699 T AT04076699 T AT 04076699T AT E499069 T1 ATE499069 T1 AT E499069T1
Authority
AT
Austria
Prior art keywords
controlled release
polymer solution
liquid polymer
bioactive substances
casing
Prior art date
Application number
AT04076699T
Other languages
English (en)
Inventor
Rey T Chern
Joel R Zingerman
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE499069T1 publication Critical patent/ATE499069T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT04076699T 1998-03-19 1999-03-18 Flüssige polymerlosung zur kontrollierten freisetzung von bioaktiven substanzen ATE499069T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7957498P 1998-03-19 1998-03-19
GBGB9815801.7A GB9815801D0 (en) 1998-07-21 1998-07-21 Liquid polymeric compositions for controlled released bioactive substances

Publications (1)

Publication Number Publication Date
ATE499069T1 true ATE499069T1 (de) 2011-03-15

Family

ID=10835852

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04076699T ATE499069T1 (de) 1998-03-19 1999-03-18 Flüssige polymerlosung zur kontrollierten freisetzung von bioaktiven substanzen

Country Status (10)

Country Link
JP (1) JP4829405B2 (de)
AT (1) ATE499069T1 (de)
DE (1) DE69943225D1 (de)
DK (1) DK1484033T3 (de)
GB (1) GB9815801D0 (de)
GE (1) GEP20033012B (de)
PT (1) PT1484033E (de)
RS (1) RS49840B (de)
SI (1) SI1484033T1 (de)
UA (1) UA53788C2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8362086B2 (en) * 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
CA2867079A1 (en) * 2012-03-13 2013-09-19 Bayer New Zealand Limited Long acting compositions
RU2690006C2 (ru) * 2013-09-16 2019-05-30 Мерк Шарп И Доум Корп. Композиции антагонистов рецепторов cgrp
KR102101969B1 (ko) * 2017-09-06 2020-04-22 (주)인벤티지랩 목시덱틴을 포함하는 마이크로 입자 및 이의 제조 방법

Also Published As

Publication number Publication date
GB9815801D0 (en) 1998-09-16
DK1484033T3 (da) 2011-06-14
UA53788C2 (uk) 2003-02-17
DE69943225D1 (de) 2011-04-07
RS49840B (sr) 2008-08-07
JP4829405B2 (ja) 2011-12-07
PT1484033E (pt) 2011-04-21
SI1484033T1 (sl) 2011-06-30
JP2002506797A (ja) 2002-03-05
GEP20033012B (en) 2003-07-25
YU54100A (sh) 2002-11-15

Similar Documents

Publication Publication Date Title
BR9908893B1 (pt) Composição polimérica líquida para a liberação controlada de substâncias bioativas hidrofóbicas.
DE69121675D1 (de) Mikrosphäre enthaltende pharmazeutische Zusammensetzung mit kontrollierter Freigabe und Verfahren zur Herstellung
DE60023520D1 (de) Flüssiges hochvisköses system mit gesteuerter freisetzung und medizinische oder chirurgische vorrichtung
DE69940735D1 (de) Biologisch abbaubare anordnungen zur kontrollierten freigabe eingeschlossener substanzen
DK561588D0 (da) Implanterbart biologisk nedbrydeligt system til frigivelse af biologisk virksomme stoffer
FR2679450B1 (fr) Procede pour la preparation de microspheres en matiere polymere biodegradable, pour la liberation controlee de substances medicamenteuses peptidiques.
BR8707631A (pt) Materiais e dispositivos cirurgicos
MY118835A (en) Sustained release compositions and the process for their preparation
DK88385A (da) Biologisk nedbrydeligt polypeptid samt anvendelse deraf til gradvis frigivelse af laegemidler
ATE222487T1 (de) Brausemittel und dessen herstellung
KR930016091A (ko) 거의 수불용성인 약제의 고체 분산액을 제조하는 방법
BR9507313B8 (pt) composição líquida de liberação adequada para a formação de um implante de liberação controlada, sistema polimérico, curativo fílmico microporoso biodegradável, e, precursor de um implante de liberação controlada para a implantação em um indivíduo
DE3879853D1 (de) Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien.
DE58902022D1 (de) Markraumsperre.
BR9607752A (pt) Formulação farmacêutica de microcápsula de liberação controlada, processo para sua preparação, e, processo de uso das microcápsulas
FI932761A0 (fi) Foerfarande foer framstaellning av aktiva substanser innehaollande mikropartiklar av hydrolytiskt nedbrytbara polymerer
ATE210427T1 (de) Verfahren zur herstellung von arzneimittelenthaltenden gefriergetrockneten formulierungen
DE59506057D1 (de) Kollagenzubereitung zur gesteuerten abgabe von wirkstoffen
ATE281155T1 (de) Medikamentöse verabreichung von proteinen aus polymergemischen
DE59703693D1 (de) Pflanzenbehandlungsmittel
SE9704400D0 (sv) Porous inorganic particles as carriers for drug substances
ATE247981T1 (de) Proteinenthaltende pharmazeutische zubereitung
DE69943225D1 (de) Flüssige Polymerlosung zur Kontrollierten freisetzung von bioaktiven substanzen
SE8601563D0 (sv) Matrismaterial, forfarande for framstellning derav och anvendning derav
GR1000266B (el) Μεθοδος παρασκευης μιας συνθεσης βασισμενης σε πολυεστερα για την ελεγχομενη εκλυση φαρμακευτικων ουσιων.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1484033

Country of ref document: EP